By Sarina Isaacs
Vicarious Surgical on Friday said William Kelly is stepping down from his role as chief financial officer.
The Waltham, Mass.-based robotics company said Kelly, who is leaving to pursue other professional opportunities, will stay on until Jan. 2 to help the company transition his responsibilities.
Kelly has been Vicarious Surgical's CFO since January 2021. He was previously CFO at Exosome Diagnostics, a privately held life science company; and CFO at life sciences company Repligen Corp. before that. As CFO at Vicarious, his total compensation in 2023 was $1.6 million.
Vicarious said it has initiated a succession process and will provide updates as appropriate.
Write to Sarina Isaacs at sarina.isaacs@wsj.com
(END) Dow Jones Newswires
December 06, 2024 16:30 ET (21:30 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.